Impact of clinical pharmacist interventions on the clinical outcome of patients with Bipolar Disorder (BD)

Impact of clinical pharmacist interventions on the clinical outcome of patients with Bipolar Disorder (BD) in Roozbeh hospital

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210307050613N1

Enrollment

112

Registered

2021-08-21

Start date

2021-08-20

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder type 1. Bipolar Disorder

Interventions

Intervention 1: Intervention group: clinical pharmacist interventions and consultations during hospitalization then one month and three months after discharge as an outpatient. Intervention 2: Control

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients diagnosed with Bipolar Disorder type 1 based on DSM 5 criteria Patients older than 18 Taking at least one antipsychotic or mood stabilizer

Exclusion criteria

Exclusion criteria: Psychiatric comorbidities including Schizophrenia, Obsessive-Compulsive Disorder,Generalized anxiety Disorder, Panic Disorder Drug or disease induced bipolar disorder Substance abuse (other than nicotin or caffeine) since one year ago

Design outcomes

Primary

Measure	Time frame
Medication Appropriateness Index. Timepoint: During hospitalization, one month and three months after discharge. Method of measurement: Medication Appropriateness Index questionnaire.	—

Secondary

Measure	Time frame
Depression score. Timepoint: During hospitalization, one months and three months after discharge. Method of measurement: Beck Depression Inventory questionnaire.;WHOQOL-BREF (WHO Quality Of Life). Timepoint: During hospitalization, one month and three months after discharge. Method of measurement: WHO Quality Of Life questionnaire.;Adherence to treatment plan. Timepoint: During hospital stay, one month and three months after discharge. Method of measurement: Medication Adherence Rating Scale.	—

Measure

Time frame

Depression score. Timepoint: During hospitalization, one months and three months after discharge. Method of measurement: Beck Depression Inventory questionnaire.;WHOQOL-BREF (WHO Quality Of Life). Timepoint: During hospitalization, one month and three months after discharge. Method of measurement: WHO Quality Of Life questionnaire.;Adherence to treatment plan. Timepoint: During hospital stay, one month and three months after discharge. Method of measurement: Medication Adherence Rating Scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazanin Gorgzadeh

Tehran University of Medical Sciences

nazanin.gz67@gmail.com+98 21 4436 3885

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026